Impact of High-Dose Peginterferon Alfa-2A on Virological Response Rates in Patients with Hepatitis C Genotype 1: a Randomized Controlled Trial

Stuart K Roberts, Martin D Weltman, Darrell HG Crawford, Geoffrey W McCaughan, William Sievert, Wendy S Cheng, William Rawlinson, Paul V Desmond, Phillipa S Marks, Motoko Yoshihara, Bishoy Rizkalla, Jean K DePamphilis, Gregory J Dore